共 50 条
- [22] Changes in Patient Reported Outcomes in Response to Subcutaneous Abatacept or Adalimumab in Rheumatoid Arthritis: Results From the Ample (Abatacept Versus Adalimumab Comparison in Biologic Naive RA Subjects with Background Methotrexate) Trial. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S578 - S578
- [25] Efficacy and safety of abatacept in patients with rheumatoid arthritis and no prior treatment with biologics REUMATOLOGIA CLINICA, 2011, 7 (06): : 392 - 396
- [26] Changes in Patient-Reported Outcomes in Response to Subcutaneous Abatacept or Adalimumab in Rheumatoid Arthritis: Results from the AMPLE (Abatacept Versus Adalimumab Comparison in Biologic-Naive RA Subjects with Background Methotrexate) Trial JOURNAL OF RHEUMATOLOGY, 2013, 40 (06) : 1006 - 1006
- [27] 2-Year Results From The Ample (Abatacept versus Adalimumab Comparison in Biologic-Naive RA Patients with Background Methotrexate) Trial: Changes In Patient-Reported Outcomes In Response To Subcutaneous Abatacept Or Adalimumab In Rheumatoid Arthritis ARTHRITIS AND RHEUMATISM, 2013, 65 : S183 - S183
- [29] 2-Year Results from the AMPLE (Abatacept versus Adalimumab Comparison in Biologic-Naive RA Patients with Background Methotrexate) Trial: Changes in Patient-Reported Outcomes in Response to Subcutaneous Abatacept or Adalimumab in Rheumatoid Arthritis JOURNAL OF RHEUMATOLOGY, 2014, 41 (07) : 1475 - 1476